Floatz logo

475 assets in Plasma Cell Myeloma

Therapeutic assets addressing Plasma Cell Myeloma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Idp-121
Plasma Cell Myeloma
IDP Discovery Pharma S.L.P1/2CC (45)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Cd38 (Adp-Ribosyl Cyclase 1, Cyclic Adp-Ribose Hydrolase 1, Cadpr Hydrolase 1, Cadpr1)], Humanized Monoclonal Antibody
Plasma Cell Myeloma
Keymed Biosciences Co.LtdP1/2CC (45)
Isb 1442
Plasma Cell Myeloma
Ichnos Sciences SAP1/2CC (45)
Lbl-034 For
Plasma Cell Myeloma
Nanjing Leads Biolabs Co.,LtdP1/2CC (45)
lm-305
Plasma Cell Myeloma
LaNova Medicines LimitedP1/2CC (45)
mbs314
Plasma Cell Myeloma
Beijing Mabworks Biotech Co., Ltd.P1/2CC (45)
Mrna-2808
Plasma Cell Myeloma
ModernaTX, Inc.P1/2CC (45)
Nirogacestat
Plasma Cell Myeloma
Hellenic Society of HematologyP2CC (45)
Opc-415
Plasma Cell Myeloma
Otsuka Pharmaceutical Co., Ltd.P1/2CC (45)
Oricar-017
Plasma Cell Myeloma
OriCell Therapeutics Co., Ltd.P1/2CC (45)
Regn7945
Plasma Cell Myeloma
Regeneron PharmaceuticalsP1/2CC (45)
Sonrotoclax
Plasma Cell Myeloma
BeOne MedicinesP1/2CC (45)
Taselisib
Plasma Cell Myeloma
National Cancer Institute (NCI)P2CC (45)
Futibatinib
Plasma Cell Myeloma
American Society of Clinical OncologyP2CC (44)
ibi346
Plasma Cell Myeloma
Chunrui LiP1CC (44)
Oric-533 Free Base
Plasma Cell Myeloma
ORIC PharmaceuticalsP1CC (44)
18f-flt
Plasma Cell Myeloma
University of OklahomaP1CC (43)
Actinium Ac 225-Dota-Daratumumab
Plasma Cell Myeloma
City of Hope Medical CenterP1CC (43)
Alnuctamab
Plasma Cell Myeloma
CelgeneP3CC (43)
Autologous Car-T Cell Therapy Expressing The Baff-Ligand.
Plasma Cell Myeloma
Luminary TherapeuticsP1CC (43)
Autologous Muc1-Activated T-Cells
Plasma Cell Myeloma
Mayo ClinicP1CC (43)
Bcma-Cd19 Ccar T Cells
Plasma Cell Myeloma
Beijing GoBroad HospitalP1CC (43)
Budesonide
Plasma Cell Myeloma
University of UtahP2CC (43)
Cyad-211
Plasma Cell Myeloma
Celyad Oncology SAP1CC (43)
Deeptag-Gprc5D Targeted Car T-Cells
Plasma Cell Myeloma
He HuangP1CC (43)
Descartes-15
Plasma Cell Myeloma
Cartesian TherapeuticsP1CC (43)
Dual-Targeting Bcma-Gprc5D Car-T Cell Infusion
Plasma Cell Myeloma
Beijing GoBroad HospitalP1CC (43)
ezm0414
Plasma Cell Myeloma
Epizyme, Inc.P1CC (43)
ft836 car t cells
Plasma Cell Myeloma
Medical College of WisconsinP1CC (43)
Ifa
Plasma Cell Myeloma
Roswell Park Cancer InstituteP1CC (43)
Indium In 111-Dota-Daratumumab
Plasma Cell Myeloma
City of Hope Medical CenterP1CC (43)
Interleukin 18 (Recombinant Human Mutein Clone St-067)
Plasma Cell Myeloma
University of WashingtonP1CC (43)
Kappa Cd28 T Cells
Plasma Cell Myeloma
Baylor College of MedicineP1CC (43)
Kln-1010
Plasma Cell Myeloma
Kelonia Therapeutics, Inc.P1CC (43)
Liposomal Curcumin
Plasma Cell Myeloma
University Health Network, TorontoP1CC (43)
Mdc-Car-Bcma001
Plasma Cell Myeloma
Technische Universität DresdenP1CC (43)
mk-4002
Plasma Cell Myeloma
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)P1CC (43)
Mm-Specific Universal Car T Cells
Plasma Cell Myeloma
Shenzhen Geno-Immune Medical InstituteP1CC (43)
Opn-6602
Plasma Cell Myeloma
Opna Bio LLCP1CC (43)
Oxodotreotide
Plasma Cell Myeloma
Jules Bordet InstituteP1CC (43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Plasma Cell Myeloma
Mayo ClinicP1CC (43)
Rimiducid
Plasma Cell Myeloma
Poseida Therapeutics, Inc.P1/2CC (43)
sar446523
Plasma Cell Myeloma
SanofiP1CC (43)
Selvigaltin
Plasma Cell Myeloma
Roswell Park Cancer InstituteP1CC (43)
Survaxm
Plasma Cell Myeloma
Roswell Park Cancer InstituteP1CC (43)
SX682
Plasma Cell Myeloma
Roswell Park Cancer InstituteP1CC (43)
3x10 cart-38 cells
Plasma Cell Myeloma
University of PennsylvaniaP1CC (41)
br101
Plasma Cell Myeloma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1CC (41)
Car-Gprc5D
Plasma Cell Myeloma
Nanjing IASO Biotechnology Co., Ltd.P1CC (41)
Car-T(Rd140 )
Plasma Cell Myeloma
Peking University People's HospitalP1CC (41)
Showing 251 to 300 of 475 assets
PreviousPage 6 of 10Next